177 related articles for article (PubMed ID: 8809192)
1. The rat endometrial adenocarcinoma cell line RUCA-I: a novel hormone-responsive in vivo/in vitro tumor model.
Vollmer G; Schneider MR
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):103-15. PubMed ID: 8809192
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus.
Zierau O; O'Sullivan J; Morrissey C; McDonald D; Wünsche W; Schneider MR; Tenniswood MP; Vollmer G
Endocr Relat Cancer; 2004 Dec; 11(4):823-30. PubMed ID: 15613455
[TBL] [Abstract][Full Text] [Related]
3. Functions of estrogens and anti-estrogens in the rat endometrial adenocarcinoma cell lines RUCA-I and RUCA-II.
Schütze N; Kraft V; Deerberg F; Winking H; Meitinger D; Ebert K; Knuppen R; Vollmer G
Int J Cancer; 1992 Dec; 52(6):941-9. PubMed ID: 1459735
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix induces hormone responsiveness and differentiation in RUCA-I rat endometrial adenocarcinoma cells.
Vollmer G; Ellerbrake N; Hopert AC; Knauthe R; Wünsche W; Knuppen R
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):259-69. PubMed ID: 7696147
[TBL] [Abstract][Full Text] [Related]
5. Effect of the nonsteroidal antiestrogen ZK 119.010 on growth and metastasis of the EnDA endometrial carcinoma.
Horn DW; Vollmer G; von Angerer E; Schneider MR
Int J Cancer; 1994 Aug; 58(3):426-9. PubMed ID: 8050824
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin is an estrogen-repressed protein in RUCA-I rat endometrial adenocarcinoma cells.
Vollmer G; Hopert AC; Ellerbrake N; Wünsche W; Knuppen R
J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):131-9. PubMed ID: 7662586
[TBL] [Abstract][Full Text] [Related]
7. Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells.
Strunck E; Stemmann N; Hopert A; Wünsche W; Frank K; Vollmer G
J Steroid Biochem Mol Biol; 2000 Oct; 74(3):73-81. PubMed ID: 11086226
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-dependent and cell-specific regulation of gene expression in RUCA-I endometrial adenocarcinoma cells.
Hopert AC; Beyer A; Strunck E; Wünsche W; Vollmer G
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):431-8. PubMed ID: 9449246
[TBL] [Abstract][Full Text] [Related]
9. Concomitant administration of an isopropanolic extract of black cohosh and tamoxifen in the in vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells.
Nisslein T; Freudenstein J
Toxicol Lett; 2004 May; 150(3):271-5. PubMed ID: 15110078
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic regulation of clusterin mRNA in normal and malignant endometrial tissue.
Wünsche W; Tenniswood MP; Schneider MR; Vollmer G
Int J Cancer; 1998 May; 76(5):684-8. PubMed ID: 9610726
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic and antiestrogenic regulation of MMP-2 and MMP-13 mRNA in RUCA-I endometrial tumor cells in vitro and in vivo.
Tüshaus L; Hopert AC; Strunck E; Schubert C; Wünsche W; Vollmer G
Cancer Lett; 2003 Jul; 198(1):99-106. PubMed ID: 12893436
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Gong Y; Ballejo G; Murphy LC; Murphy LJ
Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
[TBL] [Abstract][Full Text] [Related]
15. The EnDA endometrial adenocarcinoma: an oestrogen-sensitive, metastasizing, in vivo tumour model of the rat.
Horn DW; Vollmer G; Deerberg F; Schneider MR
J Cancer Res Clin Oncol; 1993; 119(8):450-6. PubMed ID: 8509435
[TBL] [Abstract][Full Text] [Related]
16. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
17. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium.
Diel P; Smolnikar K; Schulz T; Laudenbach-Leschowski U; Michna H; Vollmer G
Hum Reprod; 2001 May; 16(5):997-1006. PubMed ID: 11331651
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
19. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
20. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
